2024 NHLBI Workshop Charts Promising Future Directions for ECMO-Induced Coagulopathy
Jerrold Levy, MD, Critical care physician in CTICU, Duke University School of Medicine, recently shared an insightful post on X:
”ECMO-induced coagulopathy: strategic initiatives for research and clinical practice (workshop NHLBI report). This open access 2024 summary is online and new ASH journal (BLOODVTH) not on PubMED yet. Extracorporeal Life Support Organization (ELSO) please share with your community.”
Read the full article here.
The NHLBI hosted a May 2024 workshop on ECMO-induced coagulopathy, uniting experts to tackle anticoagulation challenges and advance precision medicine approaches.
The event highlighted research gaps, innovative therapies, and opportunities for interdisciplinary collaboration to improve patient outcomes.
More news on scientific advancements in Hemostasis Today.
-
Jun 6, 2026, 17:39Kalyan Roy: Immunomodulation after Blood Transfusion
-
Jun 6, 2026, 17:37Intissar Haddiya: Can Low-Dose Rivaroxaban Improve Cardiovascular Outcomes in Patients with Advanced CKD?
-
Jun 6, 2026, 17:34Stanley Anokye: From Microcytes and Macrocytes to Target Cells
-
Jun 6, 2026, 16:53Leonardo Roever: Can a Simple Cholesterol Ratio Predict Post-Stroke Depression?
-
Jun 6, 2026, 16:21Abdulkader Jamal Eddin: ABO Blood Group, COVID-19 and Early Respiratory Outcomes in Acute PE
-
Jun 6, 2026, 15:26Yuying Zhang: Grateful to Present on CD44 as A Potential Plasma-Independent Alternative to IVIG in ITP
-
Jun 6, 2026, 15:16Don Deyo: Breakthrough Therapy for Post-Stroke Upper Limb Impairment Now Published
-
Jun 6, 2026, 15:14Julianne Chong: Components of Antithrombotic Stewardship Programs from an International Perspective
-
Jun 6, 2026, 15:13Vincent Ten Cate: The Largest Blood-Based EWAS of Atherosclerosis to Date